Cigna Group (CI)
(Delayed Data from NYSE)
$347.35 USD
+0.65 (0.19%)
Updated May 8, 2024 04:00 PM ET
After-Market: $348.79 +1.44 (0.41%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CI 347.35 +0.65(0.19%)
Will CI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CI
Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat
Here's Why Cigna (CI) is a Strong Growth Stock
CI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Cigna (CI) is a Strong Growth Stock
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Acadia Healthcare (ACHC) Shares Down 9% Despite Q1 Earnings Beat
Other News for CI
See Which Of The Latest 13F Filers Holds The Cigna Group
30 Cheap Large Cap Stocks On Sale Now For May 2024
Wall Street Analysts Are Bullish on Top Healthcare Picks
New house bill to extend COVID-era telehealth flexibilities
Cell Impact Signs Main Agreement with F.C.C.